Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

RBM3 in Testicular Cancer Diagnostics and Prognostics

a testicular cancer and diagnostic technology, applied in the field of testicular cancer, can solve the problems of evaluating and standardized, unable to define cancer entirely, and formation of cancer following precancerous proliferation stages

Inactive Publication Date: 2012-02-16
ATLAS ANTIBODIES
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No definition of cancer is entirely satisfactory from a cell biological point of view, despite the fact that cancer is essentially a cellular disease and defined as a transformed cell population with net cell growth and anti-social behavior.
This multi-step process includes several rate-limiting steps, such as addition of mutations and possibly also epigenetic events, leading to formation of cancer following stages of precancerous proliferation.
However, most of these analyses still represent basic research and have yet to be evaluated and standardized for the use in clinical medicine.
It shares some similarity with other hormones, and false positives may therefore occur.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • RBM3 in Testicular Cancer Diagnostics and Prognostics
  • RBM3 in Testicular Cancer Diagnostics and Prognostics
  • RBM3 in Testicular Cancer Diagnostics and Prognostics

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Mono-Specific Polyclonal Antibodies

1. Generation of Antigen

a) Materials and Methods

[0414]A suitable fragment of the target protein encoded by the EnsEMBL Gene ID ENSG00000102317 was selected using bioinformatic tools with the human genome sequence as template (Lindskog M et al (2005) Biotechniques 38:723-727, EnsEMBL, www.ensembl.org). The fragment was used as template for the production of a 134 amino acid long fragment corresponding to amino acids 18-151 (SEQ ID NO:1) of the RBM3 protein (SEQ ID NO:2; EnsEMBL entry no. ENSP00000365946).

[0415]A fragment of the RBM3 gene transcript containing nucleotides 281-682, of EnsEMBL entry number ENST00000376755 (SEQ ID NO:3), was isolated by a SuperscriptTM One-Step RT-PCR amplification kit with Platinum® Taq (Invitrogen) and a human total RNA pool panel as template (Human Total RNA, BD Biosciences Clontech). Flanking restriction sites Notl and Ascl were introduced into the fragment through the PCR amplification primers, to allow in-frame cl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
molecular weightaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The present disclosure provides a method for determining whether a mammalian subject belongs to a first or a second group, wherein subjects of the first group have a higher risk of having a testicular disorder than subjects of the second group, comprising the steps of: evaluating an amount of RBM3 protein or RBM3 mRNA in at least part of an earlier obtained sample comprising biological material from a testicle of said subject and determining a sample value corresponding to the evaluated amount; comparing said sample value with a predetermined reference value; and if said sample value is higher than said reference value, concluding that the subject belongs to the first group; and if said sample value is lower than or equal to said reference value, concluding that the subject belongs to the second group. Further, a prognostic method for testicular cancer is provided, as well as means and uses with prognostic and diagnostic applications.

Description

[0001]This application is a Continuation-In-Part of PCT / EP2010 / 051935, filed Feb. 16, 2010 which claims priority to PCT / SE2009 / 000091, filed Feb. 16, 2009, U.S. Provisional Application No. 61 / 169,963, filed Apr. 16, 2009, EP09158084.5, filed Apr. 16, 2009, U.S. Provisional Application No. 61 / 233,769, filed Aug. 13, 2009, EP09167847.4, filed Aug. 13, 2009, and PCT / EP2009 / 067419, filed Dec. 17, 2009. The present application also claims priority to U.S. Provisional Application No. 61 / 487,341, filed May 18, 2011 and EP11166558.4, filed May 18, 2011.FIELD OF THE PRESENT DISCLOSURE[0002]The present disclosure relates to the field of testicular cancer. Further, it relates to detection of testicular disorders, including pre-malignant stages of testicular cancer, as well as the establishment of a prognosis for testicular cancer patients.BACKGROUNDCancer[0003]Cancer is one of the most common diseases, and a major cause of death, in the western world. In general, incidence rates increase with ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68G01N33/53C07K16/00C07K7/08C07K7/06
CPCA61K31/7068C07K16/3038A61K45/06C07K2317/34C12Q1/6886C12Q2600/106C12Q2600/118C12Q2600/158G01N33/57407G01N33/57419A61K39/39533C07K16/18C07K14/4748A61K2300/00A61P35/00
Inventor JIRSTROM, KARINEBERHARD, JAKOB
Owner ATLAS ANTIBODIES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com